StockData
BrainStorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Inc. (BCLI) stock

BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.77−0.01 (-1.17%)

Close on Oct 19, 2026Market cap $8.50MP/E –Yield –

BrainStorm Cell Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BrainStorm Cell Therapeutics's price to book ratio was 47.9× on Jan 31, 2023, against 4.5× a year earlier. Over the last 5 years it ranged from 3.4× to 264.4×, with a median of 10.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202347.9×+4.7
2022Dec 30, 202243.2×+37.4
2021Dec 31, 20215.8×+0.3
2020Dec 31, 20205.5×−258.8
2019Jul 31, 2019264.4×+257.0
2018Dec 31, 20187.4×−6.9
2017Dec 29, 201714.2×+9.7
2016Dec 30, 20164.5×+1.1
2015Dec 31, 20153.4×−4.7
2014Dec 31, 20148.1×+1.1
2013Dec 31, 20137.0×−0.4
2012Dec 31, 20127.4×−3.9
2011Dec 30, 201111.3×–

More BrainStorm Cell Therapeutics figures

See a number that looks wrong?